Kanyama, C;
Molloy, SF;
Chan, AK;
Lupiya, D;
Chawinga, C;
Adams, J;
Bright, P;
... Harrison, TS; + view all
(2020)
One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi.
Clinical Infectious Diseases
, 70
(3)
pp. 521-524.
10.1093/cid/ciz454.
Preview |
Text
ciz454.pdf - Published Version Download (1MB) | Preview |
Abstract
In Malawi, 236 participants from the Advancing Cryptococcal Meningitis Treatment for Africa trial were followed for 12 months. The trial outcomes reported at 10 weeks were sustained to 1 year. One-week amphotericin B plus flucytosine was associated with the lowest 1 year mortality (27.5% [95% confidence interval, 16.3 to 44.1]).
Type: | Article |
---|---|
Title: | One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi |
Location: | United States |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1093/cid/ciz454 |
Publisher version: | https://doi.org/10.1093/cid/ciz454 |
Language: | English |
Additional information: | © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). |
Keywords: | HIV, Malawi, cryptococcal meningitis, long-term follow-up, treatment |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
URI: | https://discovery.ucl.ac.uk/id/eprint/10092799 |




Archive Staff Only
![]() |
View Item |